A spotlight on the Pharmalys Regulatory Affairs Unit

Jul 15, 2025 | Quality & Business Excellence

As clinical research expands rapidly across the African continent, the demand for strategic and locally grounded regulatory support is becoming more critical than ever. From clinical trial start-up to post-marketing activities, effective regulatory oversight is key to ensuring timely access to safe, effective, and high-quality health products. Recognising and anticipating this evolution, Pharmalys pays tribute to its dedicated Regulatory Affairs and Study Start-up Unit (RAS Unit), a team committed to supporting research and development with precision, regional expertise, and unwavering integrity.

In an increasingly complex regulatory environment shaped by evolving ethical standards, scientific advancements, and national requirements, the Pharmalys RAS Unit plays a pivotal role. The team supports the successful launch and conduct of clinical trials, ensures compliance across all phases of the healthcare product lifecycle, and helps safeguard the rights and well-being of research participants, all while enabling sponsors and partners to navigate Africa’s diverse regulatory landscapes with confidence.

Regulatory Affairs Management at Pharmalys

Combining deep scientific expertise with a comprehensive understanding of local, regional, and international regulatory frameworks, the RAS Unit supports every stage of the clinical development process. From early phase trials through to post-marketing surveillance, the team works with precision, responsiveness, and regional insight to deliver robust regulatory solutions tailored to each project’s unique needs.

Key services include:

  • Developing regulatory strategies tailored to local and global requirements
  • Managing overall regulatory activities and projects
  • Preparing and submitting Clinical Trial Applications (CTAs)
  • Liaising with Ethics Committees and National Regulatory Authorities
  • Reviewing Informed Consent Forms and Protocols for compliance
  • Ensuring continuous regulatory compliance throughout project life cycles
  • Preparing amendments, reports, and ensuring inspection readiness
  • Mapping regulatory intelligence and requirements
  • Supporting the establishment of local insurance
  • Managing import licensing procedures
  • Translating and/or supporting translation of regulatory documentation
  • Delivering training and capacity-building initiatives for regulatory compliance

Why Their Work Matters

In clinical research, time and trust are everything. A well-executed regulatory strategy minimises delays, preserves data integrity, and builds confidence among regulatory bodies, sponsors, investigators, and participants.

At Pharmalys, we combine our extensive local knowledge with international standards to help our partners navigate regulatory complexity across Africa with clarity and confidence.

Want to learn more or work with our team?

Contact us at regulatory@pharmalys.com to explore how we can support your project.

International Mother Language Day, 21 February 2026

International Mother Language Day, 21 February 2026

Languages shape how people learn, connect, and participate in society. On 21 February 2026, International Mother Language Day highlights the importance of linguistic diversity and inclusion under the theme “Youth Voices on Multilingual Education”. In a rapidly...

World Neglected Tropical Diseases Day 2026 | 30 January

World Neglected Tropical Diseases Day 2026 | 30 January

Neglected tropical diseases remain a daily reality for more than one billion people worldwide. Yet they are among the most solvable challenges in global health. With proven tools, coordinated action, and sustained commitment, NTDs can be prevented, treated, and...

January 2026 Newsletter: Happy New Year from Pharmalys!

January 2026 Newsletter: Happy New Year from Pharmalys!

We hope you all enjoyed a restful festive period and feel energised for the year ahead. At Pharmalys, we enter 2026 with the same sense of readiness and purpose, having wrapped up 2025 with our Annual Meeting (pictured above), which provided an opportunity to reflect...

Strengthening GCLP Compliance at MSF Epicentre Laboratory, Mbarara

Strengthening GCLP Compliance at MSF Epicentre Laboratory, Mbarara

Pharmalys is pleased to announce the successful completion of a GCLP audit at the MSF Epicentre Laboratory in Mbarara, Uganda, conducted on 13-14 November 2025. Epicentre is a Médecins Sans Frontières (MSF) satellite dedicated to epidemiology, medical research, and...

Advancing GCLP Excellence at the UCL Cancer Institute, London

Advancing GCLP Excellence at the UCL Cancer Institute, London

We are pleased to announce the successful completion of a GCLP audit at the ECMC GCLP Facility, UCL Cancer Institute, University College London, carried out on 20-21 November 2025 as part of Pharmalys’ ongoing commitment to strengthening global Good Clinical...